Jan 05, 2023 / 07:05PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Good afternoon, everyone. I'm Matt Sykes, the Life Sciences Tools and Diagnostics analyst at Goldman Sachs. And today, we have the pleasure of kicking off the new year with Agilent, Mike McMullen, CEO; and Bob McMahon, CFO. Mike, Bob, thanks for joining us today.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
Thanks, Matt.
Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director
Thanks, Matt. Happy new year to you and to your clients. And I must say, it's great to be here in a face-to-face environment again.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Certainly is. It certainly is.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystMaybe we'll start off just kind of -- I'll